P3 Health Partners Inc (PIII) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
P3 Health Partners Inc stock (PIII) is currently trading at $3.11. P3 Health Partners Inc PS ratio (Price-to-Sales) is 0.43. Analyst consensus price target for PIII is $10.25. WallStSmart rates PIII as Sell.
- PIII PE ratio analysis and historical PE chart
- PIII PS ratio (Price-to-Sales) history and trend
- PIII intrinsic value — DCF, Graham Number, EPV models
- PIII stock price prediction 2025 2026 2027 2028 2029 2030
- PIII fair value vs current price
- PIII insider transactions and insider buying
- Is PIII undervalued or overvalued?
- P3 Health Partners Inc financial analysis — revenue, earnings, cash flow
- PIII Piotroski F-Score and Altman Z-Score
- PIII analyst price target and Smart Rating
P3 Health Partners Inc
📊 No data available
Try selecting a different time range
Smart Analysis
P3 Health Partners Inc (PIII) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book. Concerns around return on equity and operating margin. Significant fundamental concerns warrant caution or avoidance.
P3 Health Partners Inc (PIII) Key Strengths (2)
Paying less than $1 for every $1 of annual revenue
Trading below book value, meaning the market prices it less than net assets
Supporting Valuation Data
P3 Health Partners Inc (PIII) Areas to Watch (6)
Company is destroying shareholder value
Losing money on operations
Revenue declining -4.70%, a shrinking business
Company is losing money with a negative profit margin
Very low institutional interest at 9.18%
Small-cap company with higher risk but more growth potential
P3 Health Partners Inc (PIII) Detailed Analysis Report
Overall Assessment
This company scores 30/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 2 register as strengths (avg 10.0/10) while 6 fall into concern territory (avg 1.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book. Valuation metrics including Price/Sales (0.43), Price/Book (0.47) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Growth concerns include Revenue Growth at -4.70%, which may limit upside. Profitability pressure is visible in Return on Equity at -202.60%, Operating Margin at -12.80%, Profit Margin at -9.07%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -202.60% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -4.70% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
PIII Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
PIII's Price-to-Sales ratio of 0.43x trades 610% above its historical average of 0.06x (95th percentile), historically expensive. The current valuation is 3% below its historical high of 0.44x set in Mar 2026, and Infinity% above its historical low of 0x in Jan 2025. Over the past 12 months, the PS ratio has expanded from ~0.0x, reflecting growing market expectations outpacing revenue growth.
Compare PIII with Competitors
Top MEDICAL CARE FACILITIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for P3 Health Partners Inc (PIII) · HEALTHCARE › MEDICAL CARE FACILITIES
The Big Picture
P3 Health Partners Inc is in a turnaround phase, with management focused on restoring profitability. Revenue reached 1.4B with 470% decline year-over-year. The company is currently unprofitable, posting a -9.1% profit margin.
Key Findings
Revenue contracted 470% YoY. Worth determining whether this is cyclical or structural.
The company is unprofitable with a -9.1% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Sector dynamics: monitor MEDICAL CARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact P3 Health Partners Inc.
Bottom Line
P3 Health Partners Inc is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(0 last 3 months)
Data sourced from SEC Form 4 filings
Last updated: 8:23:47 AM
About P3 Health Partners Inc(PIII)
NASDAQ
HEALTHCARE
MEDICAL CARE FACILITIES
USA
P3 Health Partners Inc (PIII) is an innovative healthcare organization committed to enhancing care quality and reducing costs through a robust data-driven strategy. By leveraging advanced analytics and telehealth technologies, P3 prioritizes personalized care for underserved populations while fostering an extensive network of primary care providers and specialists. As a leader in value-based care models, the company strategically collaborates with community partners to meet the rising demand for efficient healthcare solutions. With a steadfast dedication to deliver high-quality and cost-effective care, PIII is well-positioned to navigate and thrive in the evolving healthcare landscape.